According to Wall Street analysts, the average 1-year price target for BCRX is USD with a low forecast of USD and a high forecast of USD. BIOCRYST PHARMACEUTICALS INC (BCRX) Price Targets From Analysts ; , 10, $30, $14, $ ; , 10, $30, $14, $ Find out the current price target and stock forecast for BioCryst Pharmaceuticals (BCRX). BCRX's current price target is $ Learn why top analysts are making this stock forecast for BioCryst Pharmaceuticals at MarketBeat. On average, Wall Street analysts predict that Biocryst Pharmaceuticals's share price could reach $ by Aug 6, The average Biocryst Pharmaceuticals.
BioCryst Pharmaceuticals Analyst Ratings ; Total Analysts. 6 ; Consensus Rating. Buy ; Price Target. $ ; Upside. +%. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ BCRX will report FY earnings on 02/19/ Yearly Estimates. Average Price Target ; High $ ; Average $ ; Low $ The current price of BCRX is USD — it has decreased by −% in the past 24 hours. Watch BioCryst Pharmaceuticals, Inc. stock price performance more. Earnings for BioCryst Pharmaceuticals are expected to grow in the coming year, from ($) to ($) per share. Price to Earnings Ratio vs. the Market. The P/. Mean consensus. OUTPERFORM ; Number of Analysts. 11 ; Last Close Price. USD ; Average target price. USD ; Spread / Average Target. +%. According to analysts, BCRX price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. BioCryst Pharmaceuticals Inc BCRX:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date08/23/24 · 52 Week Low · Needham analyst Serge Belanger reiterates BioCryst Pharma (NASDAQ:BCRX) with a Buy and maintains $12 price target. Disclaimer: This content is for. BioCryst Pharmaceuticals Inc has a consensus price target of $ based on the ratings of 10 analysts. The high is $30 issued by HC Wainwright & Co. on. Find the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote Analyst Price Targets. Average. Current. High. View More.
Stock Price Forecast The 6 analysts with month price forecasts for BCRX stock have an average target of , with a low estimate of and a high. Average Target Price, ; Number Of Ratings, 11 ; FY Report Date, 12/ ; Last Quarter's Earnings, ; Year Ago Earnings, BioCryst Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BCRX updated stock price target summary. BioCryst Pharmaceuticals's analyst price target count is View BioCryst BCRX: BioCryst Pharmaceuticals Inc. Search for metric or datapoint. The average one-year price target for BioCryst Pharmaceuticals, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price. The average stock forecast for BioCryst Pharmaceuticals Inc (BCRX) in the next 12 months is USD. This price target corresponds to an upside of %. View BioCryst Pharmaceuticals, Inc. BCRX stock quote prices, financial information, real-time forecasts, and company news from CNN. According to our current BCRX stock forecast, the value of BioCryst Pharmaceuticals shares will rise by % and reach $ per share by August 23, Per. Is BioCryst Pharmaceuticals stock A Buy? Several short-term signals, along with a general good trend, are positive and we conclude that the current level may.
The 24 analysts offering price forecasts for BioCryst Pharmaceuticals have a median target of , with a high estimate of and a low estimate of Analyst Price Targets ; ; Average ; Current ; High. Based on the one year price targets offered by 38 analysts, the average target price for BioCryst Pharmaceuticals Inc is $ with a high estimate of. Find the latest BioCryst Pharmaceuticals Inc (BCRX) stock forecast, month price target, predictions and analyst recommendations. Wall St. Analysts' Avg. Rating History. 1M; 6M; 1Y; 3Y. Go Premium to see BCRX Wall St. Analysts' Rating. Subscribe Now. BCRX Price Target. Price Target vs.
Track Biocryst Pharmaceuticals Inc. (BCRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. See the latest BioCryst Pharmaceuticals Inc stock price (BCRX:XNAS), related Its products and candidates target the following therapeutic areas. Analyst Price Targets ; Current, US$ US$ +%. %, US$ ; Jul '25, US$ US$ +%. %, US$ BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at JMP Securities from $ to $ They now have a "market.